Clinical Trials Browser

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT05837598 2023-08-03

Adapting the Tumor Board Model for Mental Illness and Cancer

BreastGastrointestinalHead & NeckThoracic

Mental Disorders, Bipolar Disorder, Breast Neoplasms, Depressive Disorder, Major, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Neoplasms, Schizophrenia, Urogenital Neoplasms

NCT02557230 2023-07-24

Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience

Unknown

250 enrolled

Neoplasms, Urogenital Neoplasms

NCT04880681 2023-05-01

Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle

Phase NA Unknown

60 enrolled

Genitourinary

Disease, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT05597215 2022-10-27

Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies

Unknown

70 enrolled

Urogenital Neoplasms

NCT04784507 2022-04-12

En-Bloc Resection of Bladder Tumors

Phase 2 Unknown

60 enrolled

Genitourinary

Urinary Bladder Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT04831307 2021-12-03

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

Phase NA Unknown

10 enrolled

Genitourinary

Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Disease Attributes

NCT05030077 2021-09-01

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

Phase 2 Unknown

53 enrolled

Genitourinary

Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT04922047 2021-06-11

TACBIN-01

Phase 1/2 Unknown

6 enrolled

Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT04644432 2020-11-25

INDIGO

Phase 2 Unknown

30 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT04566952 2020-10-30

Carcinoma, Ovarian Epithelial, Adnexal Diseases, Carcinoma, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms

NCT04462926 2020-09-17

PSMA-PROSTAPET

Phase NA Unknown

100 enrolled

Genitourinary

Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Disease Attributes

NCT02836275 2020-04-14

IOTA-MRI

Phase NA Unknown

250 enrolled

Gynecologic

Adnexal Diseases, Cysts, Disease, Endocrine System Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Gonadal Disorders, Neoplasms, Ovarian Cysts, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms

NCT02049190 2015-06-24

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Phase 1/2 Unknown

75 enrolled

Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Clinical Trials

ANZUP2001

Adapting the Tumor Board Model for Mental Illness and Cancer

Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience

Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle

Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies

En-Bloc Resection of Bladder Tumors

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

TACBIN-01

INDIGO

ANLOLA

PSMA-PROSTAPET

IOTA-MRI

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer